4T1-hPD-L1
Strain Information
Validation Data
Fig 1. hPD-L1 expression on in vitro cultured cells of H22-hPD-L1
Fig 2. hPD-L1(BALB/c) mice were inoculated with H22-hPD-L1 subcutaneously at 1×106 cells/mouse inoculum for tumor development
Fig 3. hPD-L1 expression in tumors after in vivo growth of H22-hPD-L1 in wild type hPD-L1(BALB/c) mouse. The tumors were collected at day 11 post tumor cell inoculation.
Fig 4. hPD-L1 expression in tumors after in vivo growth of H22-hPD-L1 in wild type hPD-L1(BALB/c) mouse. The tumors were collected at day 21 post tumor cell inoculation.
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more